AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LABECKI, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LABECKI, T. D.
Agricola
Right arrow Articles by LABECKI, T. D.

American Journal of Clinical Nutrition, Vol 8, 332-336, Copyright © 1960 by The American Society for Clinical Nutrition, Inc.

Lipoproteins and Lipotropes in Atherosclerosis

THADDEUS D. LABECKI M.D.1

1 From the Heart Disease Control Unit, Mississippi State Board of Health, Jackson, Mississippi

It is obvious that coronary atherosclerosis in the human being is an end result of a number of causative factors. In contrast, the laboratory-induced lesion in the animal is most often caused by a single experimental technic. Thus, there is no common ground for comparison. There is a distinct possibility that an absolute or relative lipotropic deficiency is behind the disturbed lipoprotein metabolism, one of the atherogenetic factors in the form of the disease found in man. It is possible to demonstrate objectively the effect of lipotropic substances on lipoprotein metabolism.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1960 by The American Society for Nutrition